Which patients should be prioritised for new hepatitis C treatments?
Low viral load in hepatitis C treatment: Is a third drug necessary?
HIV test finder: a new tool for your smartphone and Facebook
Even in well-treated populations, loss to follow-up limits community viral suppression
Tenofovir safe and effective for long-term hepatitis B treatment with little bone loss
Unprotected sex reported by the majority of sexually active adolescents infected with HIV since birth
Sofosbuvir and daclatasvir dual regimen cures most people with HCV genotypes 1, 2, or 3
